1.295 LONG-TERM TREATMENT OF WRITER'S CRAMP WITH BOTULINUM TOXIN A; RETROSPECTIVE ASSESSMENT OF THE CLINICAL IMPACT

2012 ◽  
Vol 18 ◽  
pp. S70
Author(s):  
M. Baláž ◽  
M. Bareš ◽  
P. Kaňovský
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
Term Treatment ◽  
Clinical Impact ◽  
Toxin A ◽  
Writer’S Cramp ◽  
Retrospective Assessment ◽  
Writer's Cramp ◽  
Long Term Treatment

Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China

2019 ◽  
Vol 41 (3) ◽  
pp. 645-652
Author(s):  
Xiao-bo Fang ◽  
Meng-shu Xie ◽  
Zu-biao Song ◽  
Zhi-gang Zhong ◽  
Ying Wang ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Southern China ◽  
Botulinum Toxin A ◽  
Term Treatment ◽  
Toxin A ◽  
Long Term Treatment

Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp

The Lancet ◽  
1995 ◽  
Vol 346 (8968) ◽  
pp. 154-156 ◽  
Author(s):  
G.L. Sheean ◽  
N.M.F. Murray ◽  
C.D. Marsden
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
Toxin A ◽  
Writer’S Cramp ◽  
Writer's Cramp

CONDUCTING COMPARATIVE CLINICAL-PHARMACOLOGICAL EVALUATION PHARMACOTHERAPY PREPARATIONS OF BOTULINUM TOXIN A IN CHILDREN WITH CEREBRAL PALSY SYNDROME WITH MARKED SPASTICITY

2019 ◽  
Vol 25 (5-6) ◽  
pp. 293-302
Author(s):  
Anna Petrovna Solovieva ◽  
Vladimir Vladimirovich Arkhipov ◽  
Dmitry Vladimirovich Goryachev
Keyword(s):  
Cerebral Palsy ◽  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
Pharmacoeconomic Analysis ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Term Treatment ◽  
Long Term Treatment ◽  
Clinical Pharmacological Evaluation

The original methodology for retrospective clinical studies on the criteria of “efficiency/safety” and pharmacoeconomics on the criteria of “cost/effectiveness”is proposed. The results of a retrospective study of medical records in 169 patients with cerebral palsy, which showed that the use of drugs botulinum toxin type A is an important integral component in the long-term treatment of children with spastic forms of cerebral palsy. Presents the results of pharmacoeconomic analysis of the treatment of the syndrome of spasticity in cerebral palsy when used in the complex treatment of Dysport, Botox and Xeomin.

Treatment of spasticity of different origins with botulinum toxin A: long-term results

2008 ◽  
Vol 35 (S 01) ◽  
Author(s):  
K Kollewe ◽  
S Baloush ◽  
K Krampfl ◽  
H Bigalke ◽  
R Dengler ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
Long Term Results ◽  
Toxin A ◽  
Different Origins
Sign in / Sign up

Export Citation Format

Share Document